Rotavirus Vaccines Market - Global Outlook and Forecast 2022-2028

January 2022 | 75 pages | ID: R6723F25DF6EEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.

The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.

The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.

The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.

This report contains market size and forecasts of Rotavirus Vaccines in global, including the following market information:

Global Rotavirus Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Rotavirus Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Rotavirus Vaccines companies in 2021 (%)

The global Rotavirus Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Rotarix Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rotavirus Vaccines include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological and Bharat Biotech International Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rotavirus Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rotavirus Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rotavirus Vaccines Market Segment Percentages, by Type, 2021 (%)
  • Rotarix
  • RotaTeq
  • Rotavac
  • Rotavin-M1
  • Lanzhou lamb
  • Others
Global Rotavirus Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rotavirus Vaccines Market Segment Percentages, by Application, 2021 (%)
  • Adult
  • Pediatric
Global Rotavirus Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rotavirus Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rotavirus Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Rotavirus Vaccines revenues share in global market, 2021 (%)

Key companies Rotavirus Vaccines sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Rotavirus Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Bharat Biotech
  • Merck & Co., Inc
  • GlaxoSmithKline plc
  • Lanzhou Institute of Biological
  • Bharat Biotech International Limited
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rotavirus Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rotavirus Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ROTAVIRUS VACCINES OVERALL MARKET SIZE

2.1 Global Rotavirus Vaccines Market Size: 2021 VS 2028
2.2 Global Rotavirus Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Rotavirus Vaccines Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Rotavirus Vaccines Players in Global Market
3.2 Top Global Rotavirus Vaccines Companies Ranked by Revenue
3.3 Global Rotavirus Vaccines Revenue by Companies
3.4 Global Rotavirus Vaccines Sales by Companies
3.5 Global Rotavirus Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Rotavirus Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Rotavirus Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rotavirus Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 Rotavirus Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 Rotavirus Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Rotavirus Vaccines Market Size Markets, 2021 & 2028
  4.1.2 Rotarix
  4.1.3 RotaTeq
  4.1.4 Rotavac
  4.1.5 Rotavin-M1
  4.1.6 Lanzhou lamb
  4.1.7 Others
4.2 By Type - Global Rotavirus Vaccines Revenue & Forecasts
  4.2.1 By Type - Global Rotavirus Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global Rotavirus Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global Rotavirus Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Rotavirus Vaccines Sales & Forecasts
  4.3.1 By Type - Global Rotavirus Vaccines Sales, 2017-2022
  4.3.2 By Type - Global Rotavirus Vaccines Sales, 2023-2028
  4.3.3 By Type - Global Rotavirus Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Rotavirus Vaccines Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rotavirus Vaccines Market Size, 2021 & 2028
  5.1.2 Adult
  5.1.3 Pediatric
5.2 By Application - Global Rotavirus Vaccines Revenue & Forecasts
  5.2.1 By Application - Global Rotavirus Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global Rotavirus Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global Rotavirus Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Rotavirus Vaccines Sales & Forecasts
  5.3.1 By Application - Global Rotavirus Vaccines Sales, 2017-2022
  5.3.2 By Application - Global Rotavirus Vaccines Sales, 2023-2028
  5.3.3 By Application - Global Rotavirus Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Rotavirus Vaccines Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rotavirus Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Rotavirus Vaccines Revenue & Forecasts
  6.2.1 By Region - Global Rotavirus Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global Rotavirus Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global Rotavirus Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Rotavirus Vaccines Sales & Forecasts
  6.3.1 By Region - Global Rotavirus Vaccines Sales, 2017-2022
  6.3.2 By Region - Global Rotavirus Vaccines Sales, 2023-2028
  6.3.3 By Region - Global Rotavirus Vaccines Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Rotavirus Vaccines Revenue, 2017-2028
  6.4.2 By Country - North America Rotavirus Vaccines Sales, 2017-2028
  6.4.3 US Rotavirus Vaccines Market Size, 2017-2028
  6.4.4 Canada Rotavirus Vaccines Market Size, 2017-2028
  6.4.5 Mexico Rotavirus Vaccines Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Rotavirus Vaccines Revenue, 2017-2028
  6.5.2 By Country - Europe Rotavirus Vaccines Sales, 2017-2028
  6.5.3 Germany Rotavirus Vaccines Market Size, 2017-2028
  6.5.4 France Rotavirus Vaccines Market Size, 2017-2028
  6.5.5 U.K. Rotavirus Vaccines Market Size, 2017-2028
  6.5.6 Italy Rotavirus Vaccines Market Size, 2017-2028
  6.5.7 Russia Rotavirus Vaccines Market Size, 2017-2028
  6.5.8 Nordic Countries Rotavirus Vaccines Market Size, 2017-2028
  6.5.9 Benelux Rotavirus Vaccines Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Rotavirus Vaccines Revenue, 2017-2028
  6.6.2 By Region - Asia Rotavirus Vaccines Sales, 2017-2028
  6.6.3 China Rotavirus Vaccines Market Size, 2017-2028
  6.6.4 Japan Rotavirus Vaccines Market Size, 2017-2028
  6.6.5 South Korea Rotavirus Vaccines Market Size, 2017-2028
  6.6.6 Southeast Asia Rotavirus Vaccines Market Size, 2017-2028
  6.6.7 India Rotavirus Vaccines Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Rotavirus Vaccines Revenue, 2017-2028
  6.7.2 By Country - South America Rotavirus Vaccines Sales, 2017-2028
  6.7.3 Brazil Rotavirus Vaccines Market Size, 2017-2028
  6.7.4 Argentina Rotavirus Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Rotavirus Vaccines Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Rotavirus Vaccines Sales, 2017-2028
  6.8.3 Turkey Rotavirus Vaccines Market Size, 2017-2028
  6.8.4 Israel Rotavirus Vaccines Market Size, 2017-2028
  6.8.5 Saudi Arabia Rotavirus Vaccines Market Size, 2017-2028
  6.8.6 UAE Rotavirus Vaccines Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Bharat Biotech
  7.1.1 Bharat Biotech Corporate Summary
  7.1.2 Bharat Biotech Business Overview
  7.1.3 Bharat Biotech Rotavirus Vaccines Major Product Offerings
  7.1.4 Bharat Biotech Rotavirus Vaccines Sales and Revenue in Global (2017-2022)
  7.1.5 Bharat Biotech Key News
7.2 Merck & Co., Inc
  7.2.1 Merck & Co., Inc Corporate Summary
  7.2.2 Merck & Co., Inc Business Overview
  7.2.3 Merck & Co., Inc Rotavirus Vaccines Major Product Offerings
  7.2.4 Merck & Co., Inc Rotavirus Vaccines Sales and Revenue in Global (2017-2022)
  7.2.5 Merck & Co., Inc Key News
7.3 GlaxoSmithKline plc
  7.3.1 GlaxoSmithKline plc Corporate Summary
  7.3.2 GlaxoSmithKline plc Business Overview
  7.3.3 GlaxoSmithKline plc Rotavirus Vaccines Major Product Offerings
  7.3.4 GlaxoSmithKline plc Rotavirus Vaccines Sales and Revenue in Global (2017-2022)
  7.3.5 GlaxoSmithKline plc Key News
7.4 Lanzhou Institute of Biological
  7.4.1 Lanzhou Institute of Biological Corporate Summary
  7.4.2 Lanzhou Institute of Biological Business Overview
  7.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Major Product Offerings
  7.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Sales and Revenue in Global (2017-2022)
  7.4.5 Lanzhou Institute of Biological Key News
7.5 Bharat Biotech International Limited
  7.5.1 Bharat Biotech International Limited Corporate Summary
  7.5.2 Bharat Biotech International Limited Business Overview
  7.5.3 Bharat Biotech International Limited Rotavirus Vaccines Major Product Offerings
  7.5.4 Bharat Biotech International Limited Rotavirus Vaccines Sales and Revenue in Global (2017-2022)
  7.5.5 Bharat Biotech International Limited Key News

8 GLOBAL ROTAVIRUS VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Rotavirus Vaccines Production Capacity, 2017-2028
8.2 Rotavirus Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Rotavirus Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ROTAVIRUS VACCINES SUPPLY CHAIN ANALYSIS

10.1 Rotavirus Vaccines Industry Value Chain
10.2 Rotavirus Vaccines Upstream Market
10.3 Rotavirus Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Rotavirus Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Rotavirus Vaccines in Global Market
Table 2. Top Rotavirus Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Rotavirus Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Rotavirus Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Rotavirus Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Rotavirus Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Rotavirus Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Rotavirus Vaccines Product Type
Table 9. List of Global Tier 1 Rotavirus Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rotavirus Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rotavirus Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Rotavirus Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Rotavirus Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Rotavirus Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Rotavirus Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Rotavirus Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Rotavirus Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Rotavirus Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Rotavirus Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Rotavirus Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Rotavirus Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Rotavirus Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Rotavirus Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Rotavirus Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Rotavirus Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Rotavirus Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Rotavirus Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Rotavirus Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Rotavirus Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Rotavirus Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Rotavirus Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Rotavirus Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Rotavirus Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Rotavirus Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Rotavirus Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Rotavirus Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Rotavirus Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Rotavirus Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Rotavirus Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Rotavirus Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Rotavirus Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Rotavirus Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Rotavirus Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Rotavirus Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Rotavirus Vaccines Sales, (K Units), 2023-2028
Table 46. Bharat Biotech Corporate Summary
Table 47. Bharat Biotech Rotavirus Vaccines Product Offerings
Table 48. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck & Co., Inc Corporate Summary
Table 50. Merck & Co., Inc Rotavirus Vaccines Product Offerings
Table 51. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. GlaxoSmithKline plc Corporate Summary
Table 53. GlaxoSmithKline plc Rotavirus Vaccines Product Offerings
Table 54. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Lanzhou Institute of Biological Corporate Summary
Table 56. Lanzhou Institute of Biological Rotavirus Vaccines Product Offerings
Table 57. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bharat Biotech International Limited Corporate Summary
Table 59. Bharat Biotech International Limited Rotavirus Vaccines Product Offerings
Table 60. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Rotavirus Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Rotavirus Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Rotavirus Vaccines Production by Region, 2017-2022 (K Units)
Table 64. Global Rotavirus Vaccines Production by Region, 2023-2028 (K Units)
Table 65. Rotavirus Vaccines Market Opportunities & Trends in Global Market
Table 66. Rotavirus Vaccines Market Drivers in Global Market
Table 67. Rotavirus Vaccines Market Restraints in Global Market
Table 68. Rotavirus Vaccines Raw Materials
Table 69. Rotavirus Vaccines Raw Materials Suppliers in Global Market
Table 70. Typical Rotavirus Vaccines Downstream
Table 71. Rotavirus Vaccines Downstream Clients in Global Market
Table 72. Rotavirus Vaccines Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Rotavirus Vaccines Segment by Type
Figure 2. Rotavirus Vaccines Segment by Application
Figure 3. Global Rotavirus Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Rotavirus Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rotavirus Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Rotavirus Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rotavirus Vaccines Revenue in 2021
Figure 9. By Type - Global Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Rotavirus Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Rotavirus Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 19. US Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 33. China Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Rotavirus Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Rotavirus Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Rotavirus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Rotavirus Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Rotavirus Vaccines by Region, 2020 VS 2027
Figure 50. Rotavirus Vaccines Industry Value Chain
Figure 51. Marketing Channels


More Publications